web analytics
July 4, 2015 / 17 Tammuz, 5775
At a Glance
News & Views
Sponsored Post


Teva’s Parkinson Drug Now Marketed in Japan

Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.

The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 and US FDA approval in 2006.

“It is estimated there are about 150,000-180,000 people diagnosed with Parkinson’s disease in Japan, many of whom are waiting for a new treatment option,” said Nancy Joseph-Ridge, M.D., General Manager of Takeda’s Pharmaceutical Development Division located in Osaka, Japan in a press release on April 27.

“We will continue working on the development in cooperation with Teva so that we can bring this medicine to Japanese patients as quickly as possible,” Joseph-Ridge said.

“This agreement represents Teva’s continued commitment to introducing our innovative medicines to patients in Japan,” added Teva Global R&D president and Chief Scientific Officer, Dr. Michael Hayden.

Teva and Takeda entered an agreement in December 2013 to develop glatiramer acetate for the treatment of multiple sclerosis.

Developed by Teva, rasagiline was initially discovered by two Haifa Technion professors, John Finberg and Moussa Youdim, who were instrumental in the early clinical development of the anti-Parkinson drug.

Parkinson’s disease is a degenerative disorder of the central nervous system, whose symptoms include shaking, rigidity, slowness of movement and difficultly with walking as well as dementia in advanced stages. An estimated seven to 10 million people suffer from the disease across the world according to the Parkinson’s Disease Foundation.

According to Teva’s website, rasagiline is a monoaxmine oxidase B (MAO-B) inhibitor that increases available synaptic dopamine in the brain, which might improve the motor symptoms characteristic of Parkinson’s, slowing the progression of the disease.

“Rasagiline has an established safety and efficacy profile…[it] will be an important product for Japan, where the number of available treatment options for Parkinson’s disease remains limited,” said Dr. Hayden.

About the Author: Anav Silverman is a regular contributor to Tazpit News Agency.


If you don't see your comment after publishing it, refresh the page.

Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.

If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.

2 Responses to “Teva’s Parkinson Drug Now Marketed in Japan”

  1. Judith Dowla says:

    TEVA is an excellent pharmaceutical company that offers a considerable amount of funds into research and is on the leading edge in finding the best possible treatment for various diseases and with a focus as well on receptors involving the nerves that become disturbed via a variety of causes. The goal is to do what is best to help the patient overcome and manage the disturbances that can make life very uncomfortable. Keep up the good work TEVA.

Comments are closed.

Current Top Story
UN Human Rights Council
UN HRC Condemns Israel (But Not Hamas) for War Crimes
Latest News Stories
UN Human Rights Council

US alone voted no on UNHRC Resolution condemning only Israel for wrongdoing in last summer’s conflict.

Rocket that hit a field in the Eshkol region on July 3, 2015

Sinai terrorists expanded their range of attack Friday, aiming rocket fire at southern Israel as well.

breaking the silence

5:21 PM The rocket landed in a field in the Eshkol region. Apparently from Sinai. 5:06 PM Channel 1 reports that citizens say they saw the rocket fly over from Sinai. 4:49 PM IDF Spox says they believe only 1 rocket was launched. The IDF is examining if the rocket was launched from the Sinai. […]

US Secy of State John Kerry and Iranian Foreign Minister Javad Zarif shake hands.

Iran is not budging in nuclear talks on its refusal to allow spot inspections of military sites.

Nothing like a Kosher frank for the 4th of July, even if this year, you have to cook it before Shabbat.

Nothing quite like Hamas terrorist supporters on the Temple Mount openly waving their flags..

Machsom Watch women came to harass IDF soldiers in Hebron but embarrassed themselves instead.

A Palestinian Authority Arab was shot and killed after he attacked an Israeli army commander driving in near Jerusalem.

The US Mennonite church votes to table an anti-Israel BDS resolution for two years.

Israel has tightened security and is on high alert for Friday Ramadan prayers.

An Arab man was caught by Border Police on his way to committing a terror attack in Hebron on Thursday night

PM Binyamin Netanyahu warns that Israel now faces a double threat: from ISIS and Iran.

The closing of the highway, comes after Israeli security officials voiced concern that Waliyat Sinai, the ISIS-affiliated terror group responsible for the attacks, may be planning to strike Israel as well.

Jerusalem’s Light Rail was attacked at least twice Thursday by Arabs hurling rocks in Shuafat — again.

Neo-Nazis who planned to march July 4 through London’s Golders Green section must now relocate to the city center.

Hamas apparently aided ISIS-linked Sinai terrorists in attacking Egyptian Army soldiers.

More Articles from Anav Silverman, Tazpit News Agency
Mirella Haggiag

Mirella Petteni Haggiag, a former Italian model from Rome, makes her way through the tombstones with a garbage bag in her hand several times of year when she visits Israel.

Destroyed headstones in the Mount of Olives cemetery.

Reminiscent of ISIS, Arabs continue to destroy Jewish graves on the Mount of Olives.

In honor of Ramadan, food vouchers totaling 1 million NIS will be provided to 2,600 needy families in the Arab community by the IFCJ.

Around 5,000 Jews continue to live in the ancient community, which according to some sources dates back to the time of King Solomon.

“We have Arab students, alongside Haredi and religious Jewish students, as well as children of foreign workers, and sabra Israelis, rich and poor”

Professor Carmi, who is a stem cell scientist, was presented with the medal and scroll personally signed by Queen Elizabeth II at the British Ambassador’s Residence.

New Polish Parliamentary Israel Allies Caucus was launched in Warsaw

Hundreds of competitors including an Israeli national team made up of both Chinese and Israelis, paddled their way to the finish line.

Printed from: http://www.jewishpress.com/news/breaking-news/tevas-parkinson-drug-now-marketed-in-japan/2014/05/29/

Scan this QR code to visit this page online: